Dr. Signoretti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-525-7437Fax+1 617-264-5169
Education & Training
Sapienza University of RomeClass of 1988
Certifications & Licensure
MA State Medical License 2017 - 2025- American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics
Publications & Presentations
PubMed
- 4 citationsPathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.Justine Panian, Ava Saidian, Kevin Hakimi, Archana Ajmera, William J Anderson
The Oncologist. 2024-10-03 - 3 citationsPerioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3...Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman
The Lancet. Oncology. 2024-08-01 - Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.David J Einstein, Brian Halbert, Thomas Denize, Sayed Matar, Destiny J West
Journal of Immunotherapy. 2024-07-15
Journal Articles
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
Press Mentions
Study Reveals Factors Influencing Outcomes in Kidney Cancer Treated with ImmunotherapyMay 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
